Dmitry Balyasny’s Nasus Pharma NSRX Stock Holding History

Dmitry Balyasny’s Portfolio NSRX Stock Details NSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.14M	Hold	898,473	–	–	﹤0.01%	1603
2026 Q1	$1.99M	Buy	+898,473	New	+$4.64M	﹤0.01%	1781

Other funds holding NSRX

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Dmitry Balyasny's NSRX Position: Q2 2026 in Review

Dmitry Balyasny held its Nasus Pharma (NSRX) position steady in Q2 2026 at 898,473 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Dmitry Balyasny first reported a position in NSRX in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold NSRX as of Q2 2026.

Dmitry Balyasny held 898,473 shares of Nasus Pharma worth $3.14M as of Q2 2026.
Dmitry Balyasny left its Nasus Pharma share count unchanged in Q2 2026.
Nasus Pharma made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1603 holding.
Dmitry Balyasny first reported a position in Nasus Pharma in Q1 2026 and has held it in 2 quarters since.
10 funds tracked by Wall St. Rank held Nasus Pharma as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.